Phase I trial of capecitabine plus everolimus (RAD001) in patients with previously treated metastatic gastric cancer

被引：0
|
作者：
Taekyu Lim
Jeeyun Lee
Duk Joo Lee
Ha Yeon Lee
Boram Han
Kyung Kee Baek
Hee Kyung Ahn
Su Jin Lee
Se Hoon Park
Joon Oh Park
Young Suk Park
Ho Yeong Lim
Kyoung-Mee Kim
Won Ki Kang
机构：
[1] University School of Medicine,Division of Hematology
[2] Sungkyunkwan University School of Medicine,Oncology, Department of Medicine, Samsung Medical Center Sungkyunkwan
来源：
Cancer Chemotherapy and Pharmacology | 2011年 / 68卷
关键词：
Gastric cancer; Everolimus; Capecitabine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：255 / 262
页数：7
相关论文
共 50 条
  • [1] Phase I trial of capecitabine plus everolimus (RAD001) in patients with previously treated metastatic gastric cancer
    Lim, Taekyu
    Lee, Jeeyun
    Lee, Duk Joo
    Lee, Ha Yeon
    Han, Boram
    Baek, Kyung Kee
    Ahn, Hee Kyung
    Lee, Su Jin
    Park, Se Hoon
    Park, Joon Oh
    Park, Young Suk
    Lim, Ho Yeong
    Kim, Kyoung-Mee
    Kang, Won Ki
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (01) : 255 - 262
  • [2] Phase II trial of capecitabine and everolimus (RAD001) combination in refractory gastric cancer patients
    Su Jin Lee
    Jongtae Lee
    Jeeyun Lee
    Se Hoon Park
    Joon Oh Park
    Young Suk Park
    Ho Yeong Lim
    Kyoung-Mee Kim
    In-Gu Do
    Sin-Ho Jung
    Dong-Seok Yim
    Won Ki Kang
    [J]. Investigational New Drugs, 2013, 31 : 1580 - 1586
  • [3] Phase II trial of capecitabine and everolimus (RAD001) combination in refractory gastric cancer patients
    Lee, Su Jin
    Lee, Jongtae
    Lee, Jeeyun
    Park, Se Hoon
    Park, Joon Oh
    Park, Young Suk
    Lim, Ho Yeong
    Kim, Kyoung-Mee
    Do, In-Gu
    Jung, Sin-Ho
    Yim, Dong-Seok
    Kang, Won Ki
    [J]. INVESTIGATIONAL NEW DRUGS, 2013, 31 (06) : 1580 - 1586
  • [4] Phase I trial of RAD001 (everolimus) plus sunitinib in patients with metastatic renal cell carcinoma
    Kroog, G. S.
    Feldman, D. R.
    Kondagunta, G. V.
    Ginsberg, M. S.
    Fischer, P. M.
    Trinos, M. J.
    Patil, S.
    Ishill, N. M.
    Motzer, R. J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [5] Phase II study of RAD001 in previously treated patients with metastatic pancreatic cancer
    Wolpin, B. M.
    Hezel, A. F.
    Ryan, D. P.
    Abrams, T. A.
    Meyerhardt, J. A.
    Blaszkowsky, L. S.
    Clark, J. W.
    Allen, B.
    Regan, E. M.
    Fuchs, C. S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [6] Phase I trial with carboplatin and RAD001 in metastatic breast cancer
    Eucker, J.
    Schwarzlose-Schwarck, S.
    Martus, P.
    Regierer, A. C.
    Schulz, C. O.
    Liu, H.
    Scholz, C. W.
    Schefe, J. H.
    Possinger, K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [7] Phase II Study of Everolimus (RAD001) in Previously Treated Small Cell Lung Cancer
    Tarhini, Ahmad
    Kotsakis, Athanasios
    Gooding, William
    Shuai, Yongli
    Petro, Daniel
    Friedland, David
    Belani, Chandra P.
    Dacic, Sanja
    Argiris, Athanassios
    [J]. CLINICAL CANCER RESEARCH, 2010, 16 (23) : 5900 - 5907
  • [8] Multicenter phase II study of RAD001 for previously treated metastatic gastric cancer (MGC): Preliminary results
    Muro, K.
    Boku, N.
    Yamada, Y.
    Nishina, T.
    Doi, T.
    Takiuchi, H.
    Tajima, T.
    Takahashi, A.
    Fujita, Y.
    Ohtsu, A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [9] Phase II study of RAD001 (everolimus) in previously treated small cell lung cancer (SCLC)
    Kotsakis, A. P.
    Tarhini, A.
    Petro, D.
    Flaugh, R.
    Vallabhaneni, G.
    Belani, C. P.
    Friedland, D.
    Argiris, A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [10] Phase II study of RAD001 (Everolimus) in previously treated small cell lung cancer (SCLC)
    Owonikoko, T. K.
    Stoller, R. G.
    Petro, D.
    Flaugh, R.
    Hershberger, P. A.
    Belani, C. P.
    Argiris, A. E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345